Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{4d53a6527ddd443cbec4374444e0d3cf,
title = "Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort",
abstract = "Background and aim: Airflow limitation may be found in patients with both asthma and COPD and is often associated with more symptoms and poorer outcome. We aimed to identify factors associated with airflow limitation in a well-characterized, population-based sample of adults.Methods: From the Health2006 cohort, we selected participants aged ≥35 years at enrolment (n=2,959). Airflow limitation was defined as FEV1/FVC < lower limit of normal. Participants with (cases) and without (controls) airflow limitation were compared with regard to self-reported symptoms, medical history, atopy, lung function and exhaled nitric oxide. Between-group differences were analyzed using Chi-square and Mann-Whitney U tests, and effect size was estimated by logistic regression (reported as OR and 95% CI).Results: We identified 313 cases, majority of which were female, reported poor overall health, physically inactivity and experienced respiratory symptoms within the previous year. The presence of airflow limitation was associated with BMI (OR 3.1 for overweight, P<0.001, CI 1.97-4.78), age (OR 2.3, P<0.001 for age 55+, CI 1.7-3.2), tobacco exposure (OR 1.6, P=0.01, CI 1.1-2.32, and OR 1.76, P=0.019, CI 1.2-2.3 for former and current smokers, respectively), sex (OR 1.6 for being female, P=0.002, CI 1.2-2.2), presence of specific IgE to common aeroallergen(s) (OR 1.4, P=0.041, CI 1.2-2.0), and ever being diagnosed with asthma (OR 1.6, P=0.003, CI 1.3-2.0).Conclusion: Apart from tobacco exposure and age, the presence of airflow limitation was associated with being overweight, female, sensitized to common aeroallergens or ever having a diagnosis of asthma.",
keywords = "COPD, asthma, cohort study, epidemiology, risk factors",
author = "Baarnes, {Camilla Boslev} and Thuesen, {Betina H} and Allan Linneberg and Ulrik, {Charlotte Suppli}",
year = "2019",
month = mar,
day = "26",
doi = "10.2147/COPD.S173815",
language = "English",
volume = "14",
pages = "713--718",
journal = "International Journal of Chronic Obstructive Pulmonary Disease",
issn = "1178-2005",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort

AU - Baarnes, Camilla Boslev

AU - Thuesen, Betina H

AU - Linneberg, Allan

AU - Ulrik, Charlotte Suppli

PY - 2019/3/26

Y1 - 2019/3/26

N2 - Background and aim: Airflow limitation may be found in patients with both asthma and COPD and is often associated with more symptoms and poorer outcome. We aimed to identify factors associated with airflow limitation in a well-characterized, population-based sample of adults.Methods: From the Health2006 cohort, we selected participants aged ≥35 years at enrolment (n=2,959). Airflow limitation was defined as FEV1/FVC < lower limit of normal. Participants with (cases) and without (controls) airflow limitation were compared with regard to self-reported symptoms, medical history, atopy, lung function and exhaled nitric oxide. Between-group differences were analyzed using Chi-square and Mann-Whitney U tests, and effect size was estimated by logistic regression (reported as OR and 95% CI).Results: We identified 313 cases, majority of which were female, reported poor overall health, physically inactivity and experienced respiratory symptoms within the previous year. The presence of airflow limitation was associated with BMI (OR 3.1 for overweight, P<0.001, CI 1.97-4.78), age (OR 2.3, P<0.001 for age 55+, CI 1.7-3.2), tobacco exposure (OR 1.6, P=0.01, CI 1.1-2.32, and OR 1.76, P=0.019, CI 1.2-2.3 for former and current smokers, respectively), sex (OR 1.6 for being female, P=0.002, CI 1.2-2.2), presence of specific IgE to common aeroallergen(s) (OR 1.4, P=0.041, CI 1.2-2.0), and ever being diagnosed with asthma (OR 1.6, P=0.003, CI 1.3-2.0).Conclusion: Apart from tobacco exposure and age, the presence of airflow limitation was associated with being overweight, female, sensitized to common aeroallergens or ever having a diagnosis of asthma.

AB - Background and aim: Airflow limitation may be found in patients with both asthma and COPD and is often associated with more symptoms and poorer outcome. We aimed to identify factors associated with airflow limitation in a well-characterized, population-based sample of adults.Methods: From the Health2006 cohort, we selected participants aged ≥35 years at enrolment (n=2,959). Airflow limitation was defined as FEV1/FVC < lower limit of normal. Participants with (cases) and without (controls) airflow limitation were compared with regard to self-reported symptoms, medical history, atopy, lung function and exhaled nitric oxide. Between-group differences were analyzed using Chi-square and Mann-Whitney U tests, and effect size was estimated by logistic regression (reported as OR and 95% CI).Results: We identified 313 cases, majority of which were female, reported poor overall health, physically inactivity and experienced respiratory symptoms within the previous year. The presence of airflow limitation was associated with BMI (OR 3.1 for overweight, P<0.001, CI 1.97-4.78), age (OR 2.3, P<0.001 for age 55+, CI 1.7-3.2), tobacco exposure (OR 1.6, P=0.01, CI 1.1-2.32, and OR 1.76, P=0.019, CI 1.2-2.3 for former and current smokers, respectively), sex (OR 1.6 for being female, P=0.002, CI 1.2-2.2), presence of specific IgE to common aeroallergen(s) (OR 1.4, P=0.041, CI 1.2-2.0), and ever being diagnosed with asthma (OR 1.6, P=0.003, CI 1.3-2.0).Conclusion: Apart from tobacco exposure and age, the presence of airflow limitation was associated with being overweight, female, sensitized to common aeroallergens or ever having a diagnosis of asthma.

KW - COPD

KW - asthma

KW - cohort study

KW - epidemiology

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85064892180&partnerID=8YFLogxK

U2 - 10.2147/COPD.S173815

DO - 10.2147/COPD.S173815

M3 - Journal article

C2 - 30988605

VL - 14

SP - 713

EP - 718

JO - International Journal of Chronic Obstructive Pulmonary Disease

JF - International Journal of Chronic Obstructive Pulmonary Disease

SN - 1178-2005

ER -

ID: 57016596